|
1
|
Andre F, Slimane K, Bachelot T, et al:
Breast cancer with synchronous metastases: trends in survival
during a 14-year period. J Clin Oncol. 22:3302–3308. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giordano SH, Buzdar AU, Smith TL, et al:
Is breast cancer survival improving? Cancer. 100:44–52. 2004.
View Article : Google Scholar
|
|
3
|
Li J and Zhan Q: The role of centrosomal
Nlp in the control of mitotic progression and tumourigenesis. Br J
Cancer. 104:1523–1528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bettencourt-Dias M and Glover DM:
Centrosome biogenesis and function: Centrosomics brings new
understanding. Nat Rev Mol Cell Biol. 8:451–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Doxsey SJ: Centrosomes as command centres
for cellular control. Nat Cell Biol. 3:E105–108. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raff JW: Centrosomes: Central no more?
Curr Biol. 11:R159–R161. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lingle WL, Lutz WH, Ingle JN, et al:
Centrosome hypertrophy in human breast tumors: Implications for
genomic stability and cell polarity. Proc Natl Acad Sci USA.
95:2950–2955. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krämer A, Neben K and Ho AD: Centrosome
aberrations in hematological malignancies. Cell Biol Int.
29:375–383. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nigg EA: Origins and consequences of
centrsome aberrations in human cancers. Int J Cancer.
119:2717–2723. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shao S, Liu R, Wang Y, et al: Centrosomal
Nlp is an oncogenic protein that is gene-amplified in human tumors
and causes spontaneous tumorigenesis in transgenic mice. J Clin
Invest. 120:498–507. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu D, Qu H, Fu M, et al: Increased
expression of Nlp, a potential oncogene in ovarian cancer and its
implication in carcinogenesis. Gynecol Oncol. 110:230–236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu L, Song Y, Zhang Q, et al: Ninein-like
protein is overexpressed in head and neck squamous cell carcinoma
and contributes to cancer growth and resistance to apoptosis. Oncol
Rep. 22:789–798. 2009.PubMed/NCBI
|
|
13
|
Pihan GA, Wallace J, Zhou Y, et al:
Centrosome abnormalities and chromosome instability occur together
in pre-invasive carcinomas. Cancer Res. 63:1398–1404.
2003.PubMed/NCBI
|
|
14
|
Pihan GA, Purohit A, Wallace J, et al:
Centrosome defects can account for cellular and genetic changes
that characterize prostate cancer progression. Cancer Res.
61:2212–2219. 2001.PubMed/NCBI
|
|
15
|
Duensing S: A tentative classification of
centrosome abnormalities in cancer. Cell Biol Int. 29:352–359.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu L, Song Y, Zhang Q, et al: Ninein-like
protein is overexpressed in head and neck squamous cell carcinoma
and contributes to cancer growth and resistance to apoptosis. Oncol
Rep. 22:789–798. 2009.PubMed/NCBI
|
|
18
|
Qu D, Qu H, Fu M, et al: Increased
expression of Nlp, a potential oncogene in ovarian cancer and its
implication in carcinogenesis. Gynecol Oncol. 110:230–236. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
D’Assoro AB, Lingle WL and Salisbury JL:
Centrosome amplification and the development of cancer. Oncogene.
21:6146–6153. 2002. View Article : Google Scholar
|
|
20
|
Duensing S: A tentative classification of
centrosome abnormalities in cancer. Cell Biol Int. 29:352–359.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Yang H, Liu H, et al: Effect of
staurosporine on the mobility and invasiveness of lung
adenocarcinoma A549 cells: An in vitro study. BMC Cancer.
9:1742009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhi YH, Song MM, Wang PL, et al:
Suppression of matrix metallo-proteinase-2 via RNA interference
inhibits pancreatic carcinoma cell invasiveness and adhesion. World
J Gastroenterol. 15:1072–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng Y, Broder CC, Kennedy PE, et al:
HIV-1 entry cofactor: Functional cDNA cloning of a
seven-transmembrane, G protein-coupled receptor. Science.
272:872–877. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Juarez J, Bendall L and Bradstock K:
Chemokines and their receptors as therapeutic targets: The role of
the SDF-1/CXCR4 axis. Curr Pharm Des. 10:1245–1259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hiller D and Chu QD: CXCR4 and axillary
lymph nodes: review of a potential biomarker for breast cancer
metastasis. Int J Breast Cancer. 4209812011.
|
|
26
|
Chu QD, Panu L, Holm NT, et al: High
chemokine receptor CXCR4 level in triple negative breast cancer
specimens predicts poor clinical outcome. J Surg Res. 159:689–695.
2010. View Article : Google Scholar
|
|
27
|
Hernandez L, Magalhaes MA, Coniglio SJ, et
al: Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Breast Cancer Res. 13:R1282011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cojoc M, Peitzsch C, Trautmann F, et al:
Emerging targets in cancer management: role of the CXCL12/CXCR4
axis. OncoTargets Ther. 6:1347–1361. 2013.
|
|
29
|
Zhang Z, Ni C, Chen W, et al: Expression
of CXCR4 and breast cancer prognosis: a systematic review and
meta-analysis. BMC Cancer. 14:492014. View Article : Google Scholar : PubMed/NCBI
|
